Abstract: A device for medium separation, in particular for separation of gases, such as air, from a fluid, such as oil, has a separating device (22) accommodated in a housing (1). When the medium is received via an inlet point (24) of the housing (1), this medium is rotated for the separation. The housing (1) has at least one outlet point (26) for gas and at least one outlet point (16) for fluid, which outlet points are separated from one another. A filter device (40) is in the housing for the separation of particulate contamination and is arranged after the separating device (22) in the direction of flow of the fluid.

Abstract: A device for medium separation, in particular for separation of gases, such as air, from a fluid, such as oil, by means of a separating device (22), which is accommodated in a housing (1) and which, when the medium is received via an inlet point (24) of the housing (1), sets this medium in rotation for the purpose of realizing the separation, with the housing (1) having at least one outlet point (26) for gas and at least one outlet point (16) for fluid, which outlet points are separated from one another, and with a filter device (40) being arranged in the housing for the separation of particulate contamination, is characterized in that the filter device (40) is arranged after the separating device (22) when viewed in the direction of flow of the fluid.

Abstract: The disclosed invention pertains to methods for diagnosing clinical conditions that are common in hemodialysis patients and that may be related to abnormal carnitine metabolism resulting from hemodialysis. Further, the present invention pertains to methods for monitoring and improving the administration of therapeutic intravenous levocarnitine to such patients. Clinical algorithms have been developed for the clinical symptoms seen in end-stage renal disease (ESRD) patients that may be related to carnitine deficiency. Monitoring tools to assist healthcare professionals in implementing the clinical algorithms are also provided.

Abstract: An apparatus for depositing a pattern of material on a substrate includes reciprocating aperture mask. A feed magazine houses a plurality of jigs, each of the jigs configured to support a mask having apertures defining a pattern. A shuttle mechanism receives a selected jig presented by the feed magazine and establishes contact between the mask of the selected jig and the substrate. The shuttle mechanism moves the selected jig in line with the substrate and relative to the deposition source so that deposition material passes through the apertures of the mask of the selected jig to develop the pattern of the deposition material on the substrate.

Abstract: Compositions and methods for treating and/or preventing metabolic syndrome in a subject exhibiting clinical and/or biochemical manifestations of metabolic syndrome, or being predisposed to developing metabolic syndrome, or a precursor indicator for metabolic syndrome. The method comprises administering a pharmaceutically-effective form of carnitine or a pharmaceutically acceptable salt thereof, alone or in combination with another agent, optionally in sustained-release format, in an amount effective to treat at least one symptom of metabolic syndrome or a precursor indicator for metabolic syndrome.

Abstract: The disclosed invention pertains to methods for diagnosing clinical conditions that are common in hemodialysis patients and that may be related to abnormal carnitine metabolism resulting from hemodialysis. Further, the present invention pertains to methods for monitoring and improving the administration of therapeutic intravenous levocarnitine to such patients. Clinical algorithms have been developed for the clinical symptoms seen in end-stage renal disease (ESRD) patients that may be related to carnitine deficiency. Monitoring tools to assist healthcare professionals in implementing the clinical algorithms are also provided.